Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Butterton

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Bacteriology|February 29, 2000
Vibrio cholerae VibF is required for vibriobactin synthesis and is a member of the family of nonribosomal peptide synthetasesJ R Butterton, M H Choi, P I Watnick, et al.
Infection and Immunity|March 20, 1999
In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio choleraeE T Ryan, T I Crean, M John, et al.
Infection and Immunity|August 1, 1997
Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in miceE T Ryan, J R Butterton, T Zhang, et al.
Infection and Immunity|July 1, 1997
Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strainE T Ryan, J R Butterton, R N Smith, et al.
Molecular Microbiology|August 1, 1992
Characterization of a Vibrio cholerae virulence factor homologous to the family of TonB-dependent proteinsM B Goldberg, S A Boyko, J R Butterton, et al.
Clinical and Translational Science|June 19, 2017
No Pharmacokinetic Interaction Between the Hepatitis C Virus Inhibitors Elbasvir/Grazoprevir and Famotidine or PantoprazoleH-P Feng, P Vaddady, Z Guo, et al.
Infection and Immunity|July 1, 1995
Heterologous antigen expression in Vibrio cholerae vector strainsJ R Butterton, D T Beattie, C L Gardel, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2013
Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatinE G J Hulskotte, H-P Feng, F Xuan, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Bacteriology|February 29, 2000
Vibrio cholerae VibF is required for vibriobactin synthesis and is a member of the family of nonribosomal peptide synthetasesJ R Butterton, M H Choi, P I Watnick, et al.
Infection and Immunity|March 20, 1999
In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio choleraeE T Ryan, T I Crean, M John, et al.
Infection and Immunity|August 1, 1997
Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in miceE T Ryan, J R Butterton, T Zhang, et al.
Infection and Immunity|July 1, 1997
Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strainE T Ryan, J R Butterton, R N Smith, et al.
Molecular Microbiology|August 1, 1992
Characterization of a Vibrio cholerae virulence factor homologous to the family of TonB-dependent proteinsM B Goldberg, S A Boyko, J R Butterton, et al.
Clinical and Translational Science|June 19, 2017
No Pharmacokinetic Interaction Between the Hepatitis C Virus Inhibitors Elbasvir/Grazoprevir and Famotidine or PantoprazoleH-P Feng, P Vaddady, Z Guo, et al.
Infection and Immunity|July 1, 1995
Heterologous antigen expression in Vibrio cholerae vector strainsJ R Butterton, D T Beattie, C L Gardel, et al.
Antimicrobial Agents and Chemotherapy|March 27, 2013
Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatinE G J Hulskotte, H-P Feng, F Xuan, et al.
Pageof 2